News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Thousands of migrants gathered in Fnideq, prompting Spanish and Moroccan forces to reinforce the Ceuta border amid reported deaths.
  • China's coast guard patrolled east of Taiwan; Taipei condemned the maneuvers and vowed to defend its sovereignty.
  • Anthropic said Claude models accessed three organizations' live systems during cyber evaluations, halted testing and notified affected firms.
  • A review found Chinese military-linked researchers used outputs from U.S. AI models to train domestic defense systems via model distillation.
  • Asian chip and AI stocks rallied after U.S. tech earnings beat expectations, led by South Korean chipmakers and Taiwanese suppliers.
  • Unicaja Banco beat Q2 forecasts and raised its 2026 profit outlook, while Alpha Bank reported Q2 profit above estimates on tax recognition.
  • Bitcoin traded near $64,000 as unclear Fed guidance kept gains in check despite a July recovery.

Latest Articles

Polyrizon Advances Towards Human Clinical Trials: Secures First U.S. Clinical Site for NASARIX™ Allergy Blocker Clinical Trial

Polyrizon Advances Towards Human Clinical Trials: Secures First U.S. Clinical Site for NASARIX™ Allergy Blocker Clinical Trial

Polyrizon Ltd., a biotech company specializing in intranasal hydrogels, announced the signing of its first U.S. clinical trial agreement to test NASARIX™, its innovative nasal allergy blocker. The multi-center study will evaluate the safety and efficacy of the nasal spray in patients with seasonal allergic rhinitis, marking a crucial step towards c…

Onconetix Reports Q1 2026 Progress at Proteomedix AG, Including Two New Peer-Reviewed Publications and Initiation of U.S. Validation Study

Onconetix Reports Q1 2026 Progress at Proteomedix AG, Including Two New Peer-Reviewed Publications and Initiation of U.S. Validation Study

Onconetix, Inc. reported Q1 2026 progress at its Swiss subsidiary Proteomedix AG, highlighting two new peer-reviewed publications confirming the clinical utility of Proclarix, a diagnostic test to better identify clinically significant prostate cancer and reduce unnecessary biopsies. The company also launched the PRIME multi-center clinical validat…

Kustom Entertainment, Inc. Announces Global Frequencies, a Massive EDM Event Coming to Kansas City’s Azura Amphitheater on Sunday, June 28, 2026

Kustom Entertainment, Inc. Announces Global Frequencies, a Massive EDM Event Coming to Kansas City’s Azura Amphitheater on Sunday, June 28, 2026

Kustom Entertainment, Inc. announced Global Frequencies, a large-scale Electronic Dance Music event scheduled for June 28, 2026 at the Azura Amphitheater in Kansas City. Featuring top EDM artists such as DJ Diesel (Shaquille O'Neal), Loud Luxury, TroyBoi, and Alison Wonderland, this event will follow immediately after the 30th anniversary of their …

Global Mofy Strategically Participates in New Financing Round of Kimi AI’s Developer Moonshot AI, Advancing Its Global Generative AI Strategy

Global Mofy Strategically Participates in New Financing Round of Kimi AI’s Developer Moonshot AI, Advancing Its Global Generative AI Strategy

Global Mofy AI Limited, a Nasdaq-listed generative AI technology company, has strategically invested in Moonshot AI, the developer of Kimi, a leading large language model platform in China. This move is part of Global Mofy's broader global AI strategy to enhance its presence in generative AI foundation models, intelligent interaction, and digital c…

Gilead’s Shift: From Antivirals to a Long-Duration Biotech Platform

Gilead’s Shift: From Antivirals to a Long-Duration Biotech Platform

Gilead is morphing from a steady antiviral cash engine into a diversified biotech platform focused on long-duration oncology and protein-degradation partnerships. With a market cap near $165B, $10.2B in free cash flow and a 2.36% dividend yield, the stock offers a risk-reward where selective long exposure captures upside from pipeline licensing, da…

Gilat Shares Plunge After Q1 Revenue Shortfall despite EPS Beat

Gilat Shares Plunge After Q1 Revenue Shortfall despite EPS Beat

Gilat Satellite Networks tumbled in pre-market trading after reporting Q1 2026 results that beat on non-GAAP EPS but missed revenue expectations. Management held full-year revenue and adjusted EBITDA guidance steady, leaving investors with limited upside. The stock, trading near multi-month highs and following recent insider selling, fell sharply a…

Ring Energy Shares Plunge After Large Dilutive Stock Offering Is Priced

Ring Energy Shares Plunge After Large Dilutive Stock Offering Is Priced

Ring Energy priced an underwritten public offering of common stock that will add a substantial number of shares to the market, sending the company's stock sharply lower in premarket trading. The offering of 44,444,445 shares at $1.35 each is expected to generate about $60 million in gross proceeds, with underwriters holding a 30-day option to sell …

Wix.com Shares Plunge After Major Q1 Earnings Shortfall and Margin Squeeze

Wix.com Shares Plunge After Major Q1 Earnings Shortfall and Margin Squeeze

Wix.com stock tumbled 26.08% in pre-market trading after the company reported a substantial earnings shortfall for Q1 2026. Non-GAAP diluted net income per share was $0.68 versus a $1.22 consensus, a 44.3% miss, even as revenue rose 14% year-over-year to $541.2 million. Margin compression and weakness in the Partners segment, alongside ongoing conc…

Dow Inc. Climbs Pre-Market After Argus Upgrade and Recent Earnings Beat

Dow Inc. Climbs Pre-Market After Argus Upgrade and Recent Earnings Beat

Dow Inc. rose in pre-market trading after Argus Research upgraded the stock to Buy and set a $46.00 price target, reinforcing momentum from the company’s April 23 first-quarter results that topped expectations. The upgrade, plus recent analyst upward revisions and sector strength, helped lift the shares amid broader market headwinds including risin…

SEALSQ Positioned for Leadership in Orbital Quantum Security and Space-Based Data Centers with Post-Quantum Semiconductor Technology

SEALSQ Positioned for Leadership in Orbital Quantum Security and Space-Based Data Centers with Post-Quantum Semiconductor Technology

SEALSQ Corp announces its strategic focus on pioneering post-quantum semiconductor technology to secure emerging orbital AI infrastructures and space-based data centers. The company aims to become a primary provider of trusted hardware identity and quantum-resistant encryption critical for autonomous cloud services and AI processing in space, addre…

PMGC Holdings Acquires A&B Aerospace; Shares Rise Nearly 10% Premarket

PMGC Holdings Acquires A&B Aerospace; Shares Rise Nearly 10% Premarket

PMGC Holdings Inc (NASDAQ:ELAB) announced the purchase of A&B Aerospace, a California-based precision machining firm, prompting a 9.5% jump in premarket trading. The all-cash transaction for 100% of A&B's shares totals $4.5 million in base consideration, with customary post-closing adjustments. A&B recorded roughly $5.0 million in revenue and about…